Inhibition of DPAGT1 Suppresses HER2 Shedding and Trastuzumab Resistance in Human Breast Cancer

Scientists found that upregulation of dolichyl-phosphate N-acetylglucosaminyltransferase (DPAGT1) sustained high-level HER2 shedding to confer trastuzumab resistance, which was associated with poor clinical outcomes.